ABSTRACT
M
any viruses are able to alter the host cell cycle to favor their own replication or have adapted to replicate most effectively in specific cell cycle stages (1) (2) (3) (4) . The cell cycle is a series of events that describe the growth and division of a cell. In the first gap phase (G 1 ), there is a high rate of translation as components required for DNA synthesis are created. Cells can enter gap 0 (G 0 ) during G 1 phase, if mitogenic stimulants are not present where the cell metabolic rate is low. After G 1 , cells enter synthesis (S) phase, where the genome of the cell is replicated. Following this is gap 2 (G 2 ) phase, where protein synthesis and the metabolic rate are again high. Finally, in mitosis (M) phase, the DNA chromatids and cell contents are split into two daughter cells. Transition through and between phases is highly controlled by multiple regulators. Positive regulators include cyclins and cyclin-dependent kinases (CDK). To activate a CDK, binding of a partner cyclin is required to form a complex and activate its kinase activity (reviewed in reference 5). Progression through G 1 phase is controlled by retinoblastoma (Rb) protein and its bound E2F transcription factor. Rb protein is phosphorylated by binding of D-type cyclins to CDK4/6, driving cell cycle progression through early G 1 phase. S phase entry and progression are governed by cyclins A and E, which both associate with CDK2 and further phosphorylate Rb, releasing E2F and driving DNA synthesis (6) . The cyclin B family of proteins associate with CDK1 and direct progression into M phase. Negative regulators of the cell cycle include cyclin-dependent kinase inhibitors (CDI) that inhibit cyclin-CDK complexes. CDI can be split into two families, the Ink4 family and the Cip/Kip family, which have a wide range of inhibitory effects.
Viruses can either delay, arrest, or progress the cell cycle through direct interactions of viral proteins or by inducing an innate immune response to viral replication. For example, DNA viruses, including human papillomavirus, adenovirus, and simian virus 40, encode proteins that promote S phase progression to encourage viral genome replication (7) (8) (9) . Retroviruses such as human immunodeficiency virus type 1 encode proteins which cause a cell cycle arrest in the G 2 /M phase (10) . Interestingly, RNA viruses that replicate in the cytoplasm can also affect the cell cycle. Murine coronavirus promotes cell accumulation in the G 0 /G 1 phase, while hepatitis C virus induces a G 2 /M phase arrest in infected cells (1, 11) .
Noroviruses are members of the family Caliciviridae and are nonenveloped RNA viruses that cause gastroenteritis in animals and humans. The inability to culture human norovirus in a cell line has limited research and understanding of the viral replication cycle. Recently, an in vitro model for human norovirus was developed in B cells using enteric bacteria as a stimulatory factor for norovirus infection (12) .
Using murine norovirus 1 (MNV-1) as a model, replication of noroviruses can be studied in cell culture. Previous studies have demonstrated that MNV-1 can induce apoptosis through modulation of regulatory proteins (13, 14) . Cross talk between apoptosis and the cell cycle occurs due to the overlap in regulatory mechanisms. However, no viruses in the family Caliciviridae have been investigated for their ability to affect the cell cycle. Analysis of microarray data from MNV-1-infected RAW264.7 cells showed dysregulation of transcripts involved in cell cycle regulation as well as fluctuations in pathways involved in DNA replication (15, 16) . Therefore, it was considered likely that MNV-1 affects the cell cycle in infected cells.
In this study, we show that MNV-1 infection of RAW264.7 and RAW-Blue cells altered expression of key cell cycle regulatory molecules and caused an accumulation of cells in the G 0 /G 1 phase of the cell cycle. Furthermore, the conditions created by infection aid MNV-1 replication, as cells progressing through the G 1 phase supported MNV-1 replication over cells in other phases of the cell cycle.
MATERIALS AND METHODS

Cells and viruses. (i)
Bioinformatic analysis and quantitative real-time PCR. RAW264.7 cells (obtained from ATCC) were cultured in Dulbecco's modified Eagle medium (DMEM) (Life Technologies, Gaithersburg, MD) containing penicillin (100 U/ml), streptomycin (0.1 mg/ml) (Life Technologies), and 5% heat-inactivated fetal bovine serum (Thermo Fisher Scientific). Cells were passaged every 48 h and were incubated at 37°C in 5% CO 2 . Murine norovirus 1 (CW1-P3) (17) was generated through reverse genetics as previously described (18) and propagated in RAW264.7 cells. Cell debris was removed through centrifugation, and the supernatant (unpurified MNV-1) was collected.
(ii) Cell cycle analysis. RAW-Blue cells (mouse leukemic monocyte macrophage cell line) (InvivoGen, San Diego, CA) were cultured in DMEM (Life Technologies, Gaithersburg, MD) containing penicillin (100 U/ml), streptomycin (0.1 mg/ml), Normocin (100 g/ml), zeocin (200 g/ml) (Life Technologies), and 10% heat-inactivated fetal bovine serum (FBS) (Thermo Fisher Scientific). Cells were passaged every 48 h, and cells were incubated at 37°C in 5% CO 2 . MNV-1 was propagated in RAW-Blue cells and purified by ultracentrifugation through a 30% (wt/vol) sucrose cushion at 112,700 ϫ g. The pellet was resuspended in Dulbecco's phosphate-buffered saline (dPBS) and filter sterilized through a 0.45-m filter to create a purified MNV-1 stock.
Infections. Unless otherwise stated, cells were infected in medium free of antibiotics with MNV-1 at a multiplicity of infection (MOI) of 5 for viral effects on the cell cycle and an MOI of 1 for cell cycle effects on MNV-1 replication. After 1 h of virus adsorption, the medium was removed, and fresh cell medium containing 10% FBS was added. Cells were harvested at various times postinfection (p.i.) for cell cycle analysis or Western blot probing.
Expression analysis by microarray. Asynchronously growing RAW264.7 cells were seeded in 6-well plates at 8 ϫ 10 5 cells/well and then mock infected or infected with MNV-1 at an MOI of 1. At 18 h p.i., RNA was extracted using the Qiagen RNeasy minikit as per the manufacturer's instructions. Transcriptomic analysis was conducted on duplicate infected and mock-infected samples in a manner similar to that previously described (16) . GenePattern procedures were used as previously described (19) . Raw intensities were normalized using robust multiarray average (RMA) and quantile normalization using the ExpressionFileCreator and then preprocessed using PreprocessDataset. Comparison was done using ComparativeMarkerSelection. Means and ratios of means of infected to mock-infected cells were determined (Table 1) , and the false discovery rate (FDR) was estimated by ComparativeMarkerSelection using the procedure of Benjamini and Hochberg (20) . Ratios were not calculated when the mock-infected values were low (Ͻ50). The normalized data and ratios were visualized in PathVisio using WikiPathways (e.g., WP190 cell cycle) (21) . The sets with highest and lowest ratios representing genes of increased or decreased expression were analyzed for "Functional annotation clustering" using the DAVID platform (22, 23) and a Mus musculus background. A Benjamini-Hochberg correction was used to correct for multiple testing using Swiss-Prot or Gene Ontology (GO) terms. The clustering process was used to group terms with similar groups of genes, e.g., Swiss-Prot keyword "cell division" and GO biological process "cell cycle. flasks and treated with nocodazole (M1404; Sigma) at 50 ng/ml for 10 h. To generate a G 1 phase progressing population (designated G 1 Ͼ), approximately 3.5 ϫ 10 6 cells were seeded in 25-cm 2 flasks then synchronized to M phase with nocodazole treatment; the monolayer was washed 3 times, and complete medium was added. After 3 h of release, the now-G 1 phase cells were plated at 1 ϫ 10 6 cells per well in a 6-well plate. Cell cycle analysis by flow cytometry. The percentage of cells in each phase of the cell cycle was determined through propidium iodide (P4170; Sigma) staining and fluorescence-activated cell sorting (FACS) analysis of the DNA content. Cells were harvested and fixed in 3 ml ice-cold 70% ethanol. After Ͼ12 h, the cells were washed in dPBS and resuspended in staining buffer (50 g/ml propidium iodide and 0.1 mg/ml RNase A [R4875; Sigma] in dPBS) for 45 min at 37°C in 5% CO 2 . Stained cells were then washed in dPBS and analyzed using FACS (BD FACSCalibur or BD Fortessa). At least 10,000 cells were counted for each sample, and data were analyzed with MODfit L.T. 3.0 software (Verity Software House). Plaque assays. Crystal violet staining was used to quantify viral titers. The cell culture medium was collected postinfection, and plaque assays were performed as previously described (24) .
Western blot analysis. MNV-1-infected and mock-infected cells were collected postinfection and washed twice in dPBS. Cells were lysed directly in 25 l dPBS and 25 l sample buffer (120 mM Tris-HCl [pH 6.8], 5% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.01% bromophenol blue) and stored at Ϫ80°C until analyzed. Proteins were transferred to nitrocellulose membranes (Amersham Hybond-C Extra; GE Healthcare) and detected with the corresponding primary and secondary antibodies. Fluorescence of infrared secondary antibodies was detected and quantified with an Odyssey Fc imaging system (LI-COR).
Antibodies. The following antibodies were used in Western blot analysis. Primary antibodies were cyclin D1 (ab16663; Abcam), cyclin E (E-4) (sc-25303; Santa Cruz), cyclin A (H-432) (sc-751; Santa Cruz), cyclin B1 (AB2949; Abcam), cyclin B2 (AB18250; Abcam), actin (I-19) (sc-1616; Santa Cruz), and anti-MNV-1 capsid (25) . Secondary antibodies were 680RD donkey anti-goat IgG (926-68074; LI-COR), 800CW donkey antirabbit IgG (926-32213; LI-COR), and 800CW donkey anti-mouse IgG (926-32212; LI-COR).
Statistical and densitometric analysis. Western blots are shown for one of three independent experiments. Band analysis for each protein was quantified using Image Studio Lite software, and the results are presented as means and standard deviations (SD) of the three experiments. Statistics were analyzed using Student's t test. P values of Ͻ0.05 were considered statistically significant. Each protein quantification was first normalized against actin loading, before comparisons for changes (recorded as nfold) were made.
Microarray data accession number. The complete raw data set was submitted as cel files to the GEO database under accession number GSE61562.
RESULTS
Bioinformatic analysis of the cell cycle. To globally investigate cellular changes in gene expression due to MNV-1 infection, asynchronous RAW264.7 cells were infected with virus, and changes were measured after 18 h. The levels of transcripts were compared between infected and mock-infected cells using Affymetrix 430 v2 microarrays. MNV-1 infection had significant effects on many transcripts. Of the 8,500 genes affected, fewer than 10% were Ն2-fold downregulated and ϳ20% were upregulated. However, most transcripts were not significantly altered. Notably, transcripts encoding proteins in the cell cycle were reduced (e.g., cyclin B2, 10-fold), and immune response genes were highly increased (e.g., interleukin 18, over 10-fold). Those with 5-fold or greater changes in both directions were analyzed to identify enriched pathways or processes. Functional Annotation Clustering (DAVID) (22, 23) of Ն5-fold-downregulated transcripts generated 11 significant clusters of terms describing classes of genes that included terms with corrected P values of Ͻ1 ϫ 10 Ϫ6 (Table 1 ). The transcripts most significantly reduced included the Gene Ontology (GO) Biological Pathways (BP) terms "Cell cycle" (97 genes; corrected P value, 3.1 ϫ10 Ϫ53 ) and similar protein terms (Swiss-Prot) or GO terms (data not shown). Additional clusters of reduced expression included terms related to the cellular component "Chromosome" (68 genes; P, 3.3 ϫ 10 Ϫ42 ) and "Spindle" and to the molecular function "ATP binding." All 11 clusters related to cell division. This indicates that infection affects the mitotic cell cycle transcripts. Of the most reduced transcripts, several regulators of the cell cycle stood out (Fig. 1, dark green) . The reduction of cyclin A, E, and B transcripts suggests that MNV infection impairs cell cycle progression ( Table 1 ). The expression of several genes associated with the biological process "G 1 /S phase transition" (GO:0000082) are reduced Ͼ2-fold, including but not limited to Cdc25a, Cdca5, Cdk2, Cdk4, Rb1, Skp2, cyclin A2, cyclin E1, and cyclin E2. Fewer genes associated with the "G 2 /M transition" term (GO:0000086) were significantly reduced (Fig. 1) .
MNV-1 infection affects cyclin expression. An effect on cells at an RNA transcript level is likely to change expression levels of proteins. Based on the microarray data showing changes to cell cycle regulatory protein transcripts, we asked if this affected cyclin levels in MNV-1-infected cells. Asynchronously growing RAWBlue cells were infected at an MOI of 5 and harvested at various times postinfection for Western blot analysis. After immunofluorescence band analysis, each protein signal was normalized to actin, and the change was calculated (n-fold) for each time point between MNV-1-infected and mock-infected cells. MNV-1 infection caused a 0.59-fold decrease in cyclin A expression at 12 h postinfection. Cyclin B2 expression was decreased 0.56-fold at 9 h postinfection, while cyclin D1, E, and B1 showed no differences between asynchronously growing mock-infected and infected cells (Fig. 2 ). This correlates with the transcriptomic data ( Fig. 1) , where cyclin A2 and B2 decreased significantly at an mRNA level. Although there is some variation in protein expression triplicates (indicated by the error bars in Fig. 2) , the results show a significant decrease in both cyclin A and B2 expression despite fluctuations in cyclin expression in mock-infected populations. Changes to cyclin levels are supported by microarray results and were further confirmed in later experiments. We postulated that the decrease in A and B cyclins could indicate that cells were accumulating in the G 0 /G 1 phase of the cell cycle.
MNV-1 infection causes cells to accumulate in G 0 /G 1 phase of the cell cycle. Based on the observation that MNV-1 infection dysregulates regulatory cell cycle RNA transcripts, as well as expression of host cell cyclins, we asked if MNV-1 affects the cell cycle during an infection. Asynchronous RAW-Blue cells were mock infected or MNV-1 infected at an MOI of 5, and at selected times postinfection, cells were collected and analyzed by flow cytometry to compare cell cycle profiles. At 9 h postinfection, there was a 24% increase in the G 0 /G 1 phase of the cell cycle and a 26% reduction in the proportion of cells in S phase in MNV-1-infected cells compared to mock-infected cells (Fig. 3) . These results are indicative of an arrest at the G 1 /S restriction point.
Progression of MNV-1-infected cells from G 1 /S phase is reduced. To better understand the G 0 /G 1 arrest, synchronized cells were monitored for cell cycle progression through the G 1 /S restriction point. With all synchronization treatments, dosage and treatment times were first optimized to minimize effects on cell viability and viral infection. Cells were synchronized to G 1 with N-butyrate treatment and then stimulated to reenter division through replacement of N-butyrate medium. Cells were incubated for 3 h in N-butyrate-free medium prior to infection at an MOI of 5, and at selected times postrelease, cells were collected and analyzed by flow cytometry. MNV-1 infection caused a reduction in S phase entry, compared to mock-infected cells (Fig. 4) . In mock-infected cells, the G 0 /G 1 population decreases and the S phase population increases after serum addition, as cells reenter cell replication. In contrast, MNV-1-infected cells remained mostly in G 0 /G 1 phase after serum addition, indicating that the viral infection induces a G 0 /G 1 phase accumulation through either a decrease in progression through G 1 /S or a prolonging of G 0 or G 1 phase.
MNV-1 infection does not influence late-phase cell progression from M phase into G 1 phase. Another possible explanation for the G 0 /G 1 phase accumulation seen during MNV-1 infection is faster progression through the later phases of the cell cycle through to G 0 /G 1 . To test this, cells were arrested in early M phase with nocodazole treatment. Synchronized cells were then infected, and fresh medium was added to induce cell cycle progression. Cell cycle profiles were collected postrelease and analyzed with flow cytometry. In both mock-infected and MNV-1-infected cell populations, the G 2 /M population progressed through the cell cycle into the G 0 /G 1 phase after 2 h postrelease. This is shown by a 40% drop in the G 2 /M population and a simultaneous 40% increase in the G 0 /G 1 population in both mock-infected and MNV-1-infected populations (Fig. 5) . Results show that MNV-1 infection had no influence on progression of the cell cycle through the M phase to the G 0 /G 1 phase.
MNV-1 infection inhibits cyclin A expression.
Changes to cyclin expression in RNA transcripts and protein levels as well as cell cycle profiles of infected cell populations suggest that MNV-1 impacts the G 1 /S restriction point. Other RNA viruses, such as influenza virus and coronaviruses, are also known to target the G 1 /S transition as a means of manipulating the cell into a favorable phase of the cell cycle for viral replication (2, 26) . Based on these observations, we examined G 1 /S cyclin expression of infected cells passing through the G 1 /S restriction point. Cells were synchronized to the G 0 phase, infected, and simultaneously given serum to stimulate cell cycle progression. Cells reentered the cell cycle after 12 h of serum stimulation (Fig. 6A) . Cyclin D1 levels decreased slightly in infected populations compared to mock-infected cells. At 15 h postinfection, there was a significant decrease in cyclin D1 levels. Cyclin E protein levels did not change after serum stimulation or postinfection. Cyclin A is not expressed in the quiescent G 0 population; however, its level gradually increased in mock-infected cells. After 12 h, mock-infected cells expressed significant levels of cyclin A while MNV-1 prevented the accumulation of Only the genes in the "Cell cycle (Mus musculus)" pathway (WP190) are shown; the full set of data is available from NCBI GEO (accession no. GSE61562). Genes with higher mRNA expression are shown in orange to red (2-fold), and those with lower levels are in shades of green (5-fold). Those in darkest green are reduced Ͼ5-fold. Visualization used PathVisio (21) . When multiple Affymetrix probe sets correspond to a gene, more than one bar is shown. Several of the downregulated cyclin genes (designated with the format Ccnxx [e.g., Ccna2 and Ccnb2]) showed highly significant reductions and were chosen for further study.
cyclin A in infected cells. At 15 h postinfection, there was a 0.28-fold decrease in cyclin A expression between mock-infected and MNV-1-infected cells (Fig. 6C) . These results combined with the lack of effect upon progression from G 2 /M confirm that MNV-1 infection inhibits progression through the G 1 /S restriction point, possibly through inhibition of cyclin A expression. MNV-1 replication is favored in cells progressing through G 1 . MNV-1 infection caused a prolonging of the G 0 /G 1 phase in the host cell; however, it was not known if this is beneficial to viral replication. We compared MNV-1 replication in an unsynchronized population of cells to that in populations synchronized into G 0 /G 1 and G 2 /M phases by viral capsid protein expression and virus progeny titers. Cells were synchronized into G 0 with serum withdrawal, into G 1 with N-butyrate treatment, into G 2 with genistein treatment, and into M with nocodazole treatment, and a population of G 1 phase progressing cells (G 1 Ͼ) was generated by removal of nocodazole from an M phase-synchronized population to produce a population of cells synchronized into early G 1 phase prior to infection. A G 1 progressing population was included because MNV-1 may not cause a cell cycle arrest in G 1 but rather induce a prolonged G 1 phase, and hence this population of cells could mimic the cell state during an infection. The synchronized and unsynchronized populations were seeded at equal cell densities and infected with MNV-1 at an MOI of 1. At the time of infection, cells were harvested, and cell cycle analysis was performed to show cell synchronization prior to infection. All cell populations were synchronized to their desired phases preinfection (Fig. 7A) . At 9 h postinfection, cells had remained synchronized in their target cell phase during the course of infection (Fig. 7B) . MNV-1 virus levels were highest in cell populations progressing through G 1 Ͼ, with an approximately 2-fold increase in virus titer compared to that in an unsynchronized population. Synchronized populations in G 1 , G 2 , and M phases had no difference in MNV-1 replication compared to an unsynchronized population, while G 0 phase-arrested cells had the lowest levels of MNV-1 replication (Fig. 7C) . Capsid expression was measured through Western blot analysis in each of the synchronized cell populations. Expression profiles matched that of viral titers, as MNV-1 had the highest capsid expression in G 1 Ͼ cells at 2-fold that of expression levels in unsynchronized cells, while capsid expression was undetectable in the G 0 population, and G 1 , G 2 , and M phase populations had levels of capsid protein expression similar to that in an unsynchronized population (Fig. 7D) . phase of the cell cycle consistent with the observed change in cyclins. Cell cycle progression through the G 1 /S boundary was reduced, with the proportion of cells in the S phase declining due to the G 0 /G 1 population not proceeding into S phase. MNV-1 infection had no effect on progression of cells through later phases of the cell cycle, as infected cells moving through G 2 /M phases showed progression identical to that of the mock-infected population. Collectively, these results show that MNV-1 replication in RAW-Blue cells causes an accumulation of cells in the G 0 /G 1 phase due to a prolonging of the G 1 phase or an arrest of cell cycle progression through the G 1 /S restriction point.
DISCUSSION
The effect of MNV-1 infection on cyclin expression matches what is expected in a population of cells progressing through the G 1 phase. The B family of cyclins are highly expressed during cell cycle progression during late S phase until late mitosis (27, 28) . A decrease in cyclin B2, as seen during MNV-1 infection from transcriptome data and protein quantification, would suggest a decrease in cell cycle progression through G 2 /M phase. This is consistent with the effect of MNV-1 on the cell cycle, as cyclin B2 expression would be low in a G 1 phase-arrested population due to decreased S phase and G 2 /M phase cells. The D family cyclin levels are highly expressed during the G 2 phase through to the end of the G 1 phase (29) . MNV-1 infection had no significant effect on cyclin D1 expression during infection of an asynchronous population. In cells released from a G 0 arrest, a slight reduction in cyclin D1 was observed in MNV-1-infected cells at 15 h postinfection. Cyclin E is involved in the transition between the G 1 and S phases of the cell cycle. Although MNV-1 infection caused changes to cyclin E transcript levels (Table 1) , MNV-1 had no observed effect on cyclin E protein levels during infection of asynchronous cells or on cells released from quiescence. Changes in mRNA transcripts do not always correlate to changes in protein levels, as there are multiple layers regulating protein translation. Further, the signal strength for cyclin E1 and E2 transcripts was low compared to that of other cyclins (Table 1) , leading us to conclude that MNV-1 does not decrease cyclin E levels. Lastly, A cyclins are involved in several phases of the cell cycle, but predominantly S phase, where they are involved in entry and progression through S phase and into G 2 (30) . MNV-1 infection caused a reduction in cyclin A expression in asynchronous culture and prevented expression in cells released from quiescence. The downregulation of cyclin A strongly supports the G 1 phase accumulation seen during infection. We propose that the inhibition of cyclin A expression is one probable cause of the observed MNV-1 induction of the G 1 /S phase arrest. The role of cyclin D1 in MNV-1-induced cell cycle arrest is clouded by contradictory microarray results and only partial inhibition of protein expression very late in infection. We propose that the arrest induced by MNV-1 is late in the G 1 phase, where cyclin D1 would be expressed and where viral replication is at its highest. A range of factors regulates cell replication in addition to cyclins, including transcriptional and posttranslational modification, protein localization, CDK, and CDI. The mechanism by which MNV-1 induced a cyclin A protein decrease and consequent G 1 /S phase cell cycle arrest is not known. It was hypothesized that an arrest in the G 0 /G 1 phase by MNV-1 infection could create a more favorable environment for MNV-1 replication. Both MNV-1 capsid protein production and MNV-1 progeny production were highest in cells progressing through the G 1 phase. This correlates with the effect that MNV-1 has on the cell cycle, as we propose that MNV-1 infection prolongs the G 1 phase of the cell cycle by inhibiting G 1 /S transition, providing a more beneficial environment for MNV-1 replication. Numerous other RNA viruses cause arrests in the G 0 /G 1 phase of the cell cycle. Influenza A virus causes an arrest in G 0 /G 1 phase during its infection of A549 and A/WSN/33 cells through interaction of its NS1 protein with the RhoA/Rb pathway (1, 26) . This arrest was also shown to benefit influenza A virus replication, as viral titers and viral protein production increase in G 0 phase-arrested cells. Murine coronavirus induces a G 0 /G 1 phase arrest in 17CL-1 and DBT cells through inhibition of Rb phosphorylation. This is possibly caused by virus-induced degradation of host cyclins D2 and cyclin E, as well as a downregulation of CDK2 activity. MNV-1 similarly influences the host cell cycle, causing a G 0 /G 1 phase arrest that benefits its own replication. However, it cannot be excluded that the effects on the cell cycle are host driven as a consequence of MNV-1 infection and that the virus has adapted to better replicate under these conditions.
The biological significance of MNV-1-induced cell cycle arrest or prolonging of the G 1 phase is supported by more efficient MNV-1 capsid production and progeny replication. The benefit to the virus may be explained by several factors. Ribonucleotides are precursors for deoxyribonucleotides whose levels change throughout cell division. Levels of ribonucleotides drop as cells enter S phase due to the increased demand for deoxyribonucleotides (31) . A cell cycle arrest in the G 1 phase would provide increased amounts of ribonucleotide pools for MNV-1 genome synthesis. Expression of enzymes involved in the processing of ribonucleotides to deoxyribonucleotides is inhibited during MNV-1 infection. Thymidine kinase 1 (TK1), ribonucleotide reductase M2 (RRM2), and deoxyuridine triphosphatase (DUT) expression was decreased at a transcript level as shown by microarray results (Table 1) with the G 1 phase having the highest translation efficiency (32, 33) . The increased translation efficiency in the G 1 phase is exploited for recombinant protein expression by industries and may also be beneficial for MNV (34, 35) . Translation efficiency of hepatitis C virus is shown to be greatest during the G 0 /G 1 phase of the cell cycle (36) . The G 1 /S phase arrest induced by MNV may increase translation efficiency rates of MNV proteins and aid in MNV replication.
The recruitment of membranes for norovirus replication has been shown to be vital to the synthesis of viral proteins (37) . The MNV-1 replication complexes associate with the endoplasmic reticulum and Golgi apparatus (38) . During mitosis, the endoplasmic reticulum and the Golgi apparatus disassemble, and so the G 1 /S arrest seen in MNV-1-infected cells may prevent impairment of membrane structures and reduced MNV-1 replication (39, 40 ).
An induced cell arrest has the potential to protect infected cells from the host immune system. Noncycling cells are also less likely to be killed by cytotoxic T cells, making a more persistent infection and longer shedding period (41) . Several studies have described links between the cell cycle and apoptosis signaling. A delay in apoptosis is often seen following a cell cycle arrest (42, 43) . Furthermore, induction of apoptosis often requires cell cycle progression (44) . MNV-1 infection results in a cell cycle arrest for up to 12 h postinfection (data not shown). After 12 h postinfection, apop-
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Pre-infection tosis is stimulated in RAW264.7 cells, illustrated by a downregulation of survivin (15) . Thus, MNV-1-induced cell cycle arrest may prevent early death from apoptosis, allowing time for MNV replication.
The mechanism of the MNV-1 effect on the cell cycle is unknown. Microarray data for MNV-1 infection provide insights into the cell cycle response to MNV-1 infection and the global effects on cell cycle regulators. It is possible that the arrest is caused by MNV-1 proteins, but it is also plausible that this is a host response to viral infection and that MNV-1 has adapted to better replicate under these conditions. MNV-1 infection in RAW-Blue cells causes an accumulation of cells in the G 0 /G 1 phase due to a decrease in G 1 /S phase progression. Replication was furthermore favored in G 1 , a phase that results from MNV-1 replication and is more likely to better support RNA virus replication. This interaction with the cell cycle phase identified for MNV-1 may be applicable to other caliciviruses.
